A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid Tumors

NCT07730190 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

145

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignancies

Interventions

DRUG: TQB6426 for Injection

Sponsor

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.